[Approach to acute gastroenteritis in children: comparison over the years]

Related Experiment Video

Updated: Oct 27, 2026

A High-throughput Platform for the Screening of Salmonella spp./Shigella spp.
06:55

A High-throughput Platform for the Screening of Salmonella spp./Shigella spp.

Published on: November 7, 2018

G Gaeta1, G Messi, A G Marchi

  • 1Servizio di Pronto Soccorso e Primo Accoglimento, IRCCS Istituto per l'Infanzia, Trieste.

Minerva Pediatrica
|December 1, 1993
PubMed

Insights

Introducing oral rehydration solution (ORS) for acute gastroenteritis in children improved care quality and reduced hospital stays. However, parenteral fluid administration remained high despite increased ORS use.

Area of Science:

  • Pediatrics
  • Gastroenterology
  • Health Services Research

Context:

  • Acute gastroenteritis is a common cause of pediatric hospitalization.
  • Hospital records were audited retrospectively for two periods: before and after the introduction of oral rehydration solution (ORS).
  • Patient cohorts included 103 patients in period A and 133 in period B.

Purpose:

  • To evaluate the diagnostic and therapeutic approach to children hospitalized with acute gastroenteritis.
  • To assess the impact of oral rehydration solution (ORS) on treatment and hospital stay.
  • To determine the effectiveness of medical audit in improving the quality of care.

Summary:

  • Incomplete patient history taking and lack of weight loss documentation persisted across both periods.
  • Therapeutic practices in period B aligned with guidelines for antibiotic prescription and ORS use.
  • While ORS was used in over 70% of patients in period B, parenteral fluid administration did not significantly decrease compared to period A.
  • ORS use was associated with a reduced length of hospital stay in the later period.

Impact:

  • The study highlights the benefits of ORS in reducing pediatric hospital stays for gastroenteritis.
  • It underscores the continued need for comprehensive patient assessment, including weight documentation.
  • Medical audit is confirmed as a valuable tool for enhancing the quality of pediatric care for acute gastroenteritis.

More Related Videos

Culture Methods to Determine the Limit of Detection and Survival in Transport Media of Campylobacter Jejuni in Human Fecal Specimens08:23

Culture Methods to Determine the Limit of Detection and Survival in Transport Media of Campylobacter Jejuni in Human Fecal Specimens

Published on: March 10, 2020

Assessment of Intestinal Transcytosis of Neonatal Escherichia coli Bacteremia Isolates08:32

Assessment of Intestinal Transcytosis of Neonatal Escherichia coli Bacteremia Isolates

Published on: February 17, 2023

Related Concept Videos

Drugs Affecting GI Tract Motility: Antimicrobials as Antidiarrheal Agents01:18

Drugs Affecting GI Tract Motility: Antimicrobials as Antidiarrheal Agents

Acute diarrhea, a common gastrointestinal disturbance, is characterized by the rapid evacuation of fluid stools, leading to an excessive weight in fluid. This condition typically arises from disorders affecting intestinal water and electrolyte transport. It can be triggered by an increased osmotic load within the intestine, excessive secretion of electrolytes and water, mucosal exudation of protein and fluid, or altered intestinal motility. The primary risks of acute diarrhea are dehydration...
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
Bacterial Gastroenteritis01:18

Bacterial Gastroenteritis

Bacterial gastroenteritis, characterized by diarrhea, abdominal cramps, and vomiting, is often caused by ingestion of contaminated food or water and is frequently associated with pathogenic Escherichia coli strains. These microbes exploit two principal mechanisms to inflict disease.Shiga toxin–producing E. coli, also referred to as STEC—notably O157:H7—release Shiga toxins that target ribosomes, blocking protein synthesis. The B subunit of the toxin binds the host glycolipid receptor...